Piperidine derivatives useful as modulators of chemokine receptor activity
US7517989B2 · kind B2 · utility
2Cited by
19References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 2003 |
| Grant date | Apr 14, 2009 |
| Priority date | — |
| Expiry date | Dec 24, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula (I), wherein: Z is (A) OR (B) and wherein the remaining variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of achemokine (such as CCR3) or H1 mediated disease state.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.